Raloxifene Teva

ATC：G03XC01

治疗领域：Osteoporosis, Postmenopausal

药理分类：Sex hormones and modulators of the genital system

修订号：10 · 最新影响 PI 的程序：N/0029

适应症（原文）：Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. A significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. When determining the choice of raloxifene or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.